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The knowledge that bacteriophage lysis is inhibited by blood, serum, bile, 
white cells, tissue debris, etc., has caused many bacteriologists to doubt that the 
agent can retain its activity in vivo (1).  Indeed, most investigators feel that 
the beneficial effects which in some cases follow bacteriophage therapy, may 
not be due to the lyric or bactericidal effect of the agent, but rather to a number 
of other mechanisms such as the production of specific antibacterial immunity, 
or the stimulation of non-specific phagocytic activity by the bacterial and broth 
components present in the lysate  (2, 3).  There are, however, a  few reports 
which  seem to  establish  that bacteriophage per  se  can exert a  favorable in- 
fluence on certain experimental infections (4--6). 
It would seem that  the evaluation of the potential therapeutic efficacy of 
bacteriophage will be facilitated by a  knowledge of the fate of this agent fol- 
lowing its introduction into normal and infected animals.  In order to study 
this problem we have made use of the experimental disease which results from 
the intracerebral injection of Shigella dysenteriae  (Shiga) into white mice.  This 
infection takes the form of a meningitis which is usually fatal in 3 to 10 days, 
and in which extensive multiplication of the dysentery bacillus takes place in 
the brain  in the absence of generalized septicemia.  It will be shown in  the 
present paper that when anti-Shiga bacteriophage is injected into the general 
circulation of animals so infected, the agent multiplies very rapidly at the site 
of bacterial multiplication  (in the brain), and may, under the proper experi- 
mental  conditions, protect  the  animals  against  an  otherwise fatal  infection. 
EXPERIMENTAL 
Experimental Infection.--The culture used was a smooth variant of Shigella dysen. 
teriae (Shiga 2308), obtained through the kindness  of Dr.  M.  Coleman  of the De- 
* Preliminary experiments were carried out in the laboratories of the Hospital of 
The Rockefeller  Institute for Medical Research. 
The latter part of the work was done under a contract, recommended by the Com- 
mittee on Medical Research, between the Office of Scientific Research and Develop- 
ment and Harvard University. 
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partment  of Laboratories of  the  New  York  State  Department  of  Public Health, 
Albany, New York.  The culture was grown in meat extract peptone broth for 24 
to  48  hours;  appropriate dilutions  (in  warm  broth  or saline)  were  injected intra- 
cerebrally into anesthetized white mice weighing 18 to 25  gm., the final volume of 
the inoculum being 0.03  cc.  The few deaths  occurring within 3  hours  were  con- 
sidered as due to trauma and have not been included in the experimental results. 
The L  Ds0 of this culture injected by the intracerebral route is approximately 
0.00005  cc.; the injection of 0.005 cc. results in the death of 95 per cent of the infected 
animals within 2 to 5 days.  The infective organisms can be recovered in large num- 
bers from the brain of the infected animals at autopsy; peritoneal washings, on the 
contrary, always remain sterile and the heart blood gives only an occasionally  positive 
culture. 
Baaeriopkage Preparations.--The bacteriophage used  in  these  experiments  was 
obtained from New York City sewage water in 1942, and has since been propagated 
in cultures of Skigella dysenteriae 2308  (smooth phase).  No attempt has been made 
to isolate a  pure line bacteriophage from it, and in fact we have observed that our 
preparation forms plaques of at least two different sizes. 
The bacteriophage filtrates were obtained by the following technique.  Flasks con- 
taining 250 ee. of broth were inoculated with 2.5 co. of an overnight culture of Shigella 
dysenteriae 2308.  Mter 3 hours' incubation at 37  C. the culture containing approxi- 
mately 109 organisms per co., was placed in the ice box overnight (only as a matter 
of convenience), and inoculated the following morning with 0.000025  co. of bacterio- 
phage.  Mter 4 hours' incubation at 37 C.  the culture was filtered through a  Selas 
porcelain candle  (porosity 03), giving a  filtrate which contained from  7  ×  109  to 
2  ×  10  x9 bacteriophage particles  ~ per cc.  The final titre was apparently independent 
of whether or not the culture had undergone lysis at the time of filtration. 
The titre of the bacteriophage preparation was determined by plaque enumeration 
on 2 per cent agar plates, 24 to 48 hours old.  The bacteriophage filtrate was diluted 
far enough to give isolated plaques, the final dilution being made in a broth culture 
of  Skigella dysenteriae 2308.  The  final  dilutions  were  immediately spread  on  a 
quadrant  of the nutrient  agar with a  calibrated loop  (1/60  cc.),  conditions being 
arranged to obtain confluent bacterial growth.  The plaques were counted after 24 
hours. 
The bacteriophage level in the blood was established by diluting the blood obtained 
from the clipped tail in a red cell counting pipette.  When low bacteriophage numbers 
were expected, as for instance in the blood of uninfected animals, 0.25 cc. of the heart 
blood was diluted with 4  cc.  of culture, and 0.15  cc.  of the mixture spread over an 
agar plate with a bent glass rod; it will be seer that under these conditions the smallest 
blood level that could be measured corresponded to approximately 120 bacteriophage 
particles per cubic centimeter of blood. 
To determine the bacteriophage level in the brain, the cerebral hemispheres and 
cerebellum were ground in an agate mortar with 2  or 4  cc.  of saline; the material 
x The assumption is made in the presentation of the data that each plaque obtained 
on the agar plates corresponded to one bacteriophage particle in the bacteriophage 
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filtered through paper was then diluted and plated as described above in the case 
of the blood. 
TABLE I 
Bacteriophage Level in the Brain of Normal and Infected Mice aS Different Intervals 
Intraperitoneal Injection of 10  ~ Bacteriophage Particles 
Time  after 
infection 
]~r$, 
1 
16 
26 
54 
75 
Mouse No.  Normal mice 
9 
10 
11 
12 
13 
14 
15 
16 
<1.2  X  102. 
gc  c¢ 
1.2  X  109 
It  ~C 
<1.2 X  10  2 
1.2 X  10  2 
7  <1.2  X I02 
8  cc  t~ 
tg  4C 
Not tested 
<1.2 X 102 
cc  ~t 
Not tested 
Mouse No. 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
Infected mice 
1.2 ×  102. 
6.6×  10  ~ 
1.2 X  10  2 
<1.2  X  10  2 
1.2  X  103 
<1.2 X  102 
9.9 X  I0  s 
1.0 X  10  ¢ 
1.9 X  10  9 
9.2 X  10  s 
4.0 X  10  s 
2.0 X  10  9 
4.6 X  10  s 
6.6 X 10  6 
6.6 X  10  5 
<6.6 X  10  6 
* The figures refer to the number of bacteriophage particles per gram of brain material. 
<  indicates  that the number of bacteriophage particles was smaller than the smallest 
amount that could be revealed with the dilutions employed. 
The  Fate  of Bacteriophage  Injected  into  Normal  and  Infected  Mice 
Experiment  1.--A  group of mice were infected intracerebrally with 0.005  co.  of 
Skigella  dysenteriae.  Other  mice  were  kept  as  uninfected controls.  All animals 
received simultaneously with the infection 10  s bacteriophage particles by the intra- 
peritoneal route.  The animals were sacrificed  after different intervals of time (1, 2, 
4, 8,  16, 26, 54, and 75 hours after infection); and the bacteriophage content of the 
brain was determined by the method outlined above (Table I). 
The results presented in Table I  show that bacteriophage injected intraperi- 
tone.ally into normal mice reaches its maximum titre in the brain within a very 
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TABLE II 
Blood and Brain Levels of Bacteriophage in Normal and Infected Mice* 
Time 
after 
injection 
of bac- 
teriophage 
hrs. 
18 
42 
66 
90 
114 
138 
Normal mice 
Blood level  Brain  level 
No. of particles  No. of particles 
per cc.  per gin. 
6.0 X  10  4 
7.2  X  10 ~ 
3.0 X  10  7 
<6.0 X  10  4 
5.3 X  10  3 
2.6 X  10  3 
7.9 X  10  8 
2.6 X  10  3 
1.2 X  10  2 
cc  ¢c 
2.2 X  10  2 
<1.2  X  10  2 
<1.2  X  10  2 
1.2  X  10  2 
1.7 X  10  2 
<1.2  X  10  2 
3.9 X  10  i 
1.0 X  10  2 
<1.2 X  10  2 
<1.2  X  10  8 
2.9 X  10  4 
1.2 X  10  6 
<1.2  X  10  3 
<1.2  X  10  2 
5.2 X  10  2 
2.6 X  10  2 
3.9X  10  2 
<1.2  X  10  2 
1.2  X  102 
<1.2  X  10  2 
¢#  I# 
I¢  f¢ 
#¢  #g 
Mice infected  24 hrs. before 
Blood  level  Brain  level 
No. of particles  No. of particles 
per cc.  per gm. 
X  i0  ~  8.4 X  lO  s 
X  107  3.6 X  107 
X  107  7.8 X  107 
X  107  2.4 X  107 
X  10  4  6.0 X  10  5 
X  10  4  9.0 X  10  6 
X  10  4  1.5  X  10  6 
X  10  4  3.2 X  10  7 
X  10  3  1.2 X  10 s 
X  10  3  6.3 X  10  7 
X  10  3  1.2 X  10 s 
X  10  2  5.6 X  10  7 
X  10  2  7.6 X  l0 s 
X  10  3  3.0  X  l0 s 
X  10  3  1.5 X  10 9 
X  10  2  <6.6 X  10  3 
X  10  2  <1.2  X  10  2 
X  10  ~  5.8 X  10 3 
X  10  2  1.2 X  10  2 
X  10  4  9.0 X  l0 s 
X  102  <1.2  X  10  2 
Died 
3.3 
6.0 
1.4 
9.0 
8.0 
2.7 
4.9 
6.1 
1.2 
1.9 
1.3 
5.3 
9.3 
6.1 
5.3 
<1.2 
<1.2 
1.0 
<1.2 
1.0 
< 1 ..2 
Died 
* 109  bacteriophage particles injected intraperitoneally.  Mice  infected intracerebrally 
with 0.005  cc. Shigella dysenteriae 24 hours before determination of bacteriophage level. 
<  indicates that the number of bacteriophage particles was smaller than the smallest 
amount that could be revealed with the dilutions employed. 
hand,  the  bacteriophage multiplies  in  the  brain  to  reach  in  12  to  18  hours 
maximum levels far higher than the total amount originally injected, indicating, 
therefore, multiplication of the agent in vivo. 
Experiment 2.--A group of mice received 109 bacteriophage corpuscles by the intra- 
peritoneal route.  Some of the animals were sacrificed after 18,  42, 66, 90,  114,  and 
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Mter the same intervals of time similar groups of animals were infected by the intra- 
cerebral route with 0.005 cc. of Shigdla dysenteriae, and sacrificed 24 hours later. 
This procedure permitted a comparison  of the bacteriophage levels in the blood and 
brain of infected and uninfected mice at various times after the administration of 
bacteriophage (Table II). 
It is clear from the results presented in Table II that, in uninfected mice, the 
bacteriophage in the blood rapidly reaches a titre compatible with the numbers 
that  could be expected if the total number of particles injected were simply 
diluted in the total fluid volume of the mouse.  The brain level remains at all 
times below that of the blood, perhaps due to the small blood content of the 
brain.  Both the blood and brain levels begin to fall a few hours after injection 
of the bacteriophage and, in fact, after 4 days the bacteriophage level in some of 
the mice was too low to be measured by the titration method employed. 
In infected animals one observed immediately a  very great increase in the 
number of bacteriophage particles, the increase being much more pronounced in 
the brain than in the blood; this situation which is in marked contrast with that 
which obtained in the uninfected animals (where brain levels were much lower 
than blood levels) is probably due to the fact that the experimental infection 
remains localized in the brain and that the bacteriophage can multiply only at 
the site of bacterial multiplication.  It appears therefore that the blood level is 
only a  reflection of the events occurring in the brain. 
Protective Effect  of Bacteriophage against Infection 
Experiment 3.--Twenty-four mice were infected intracerebrally with 0.005 co. of 
Shigella dysenteriae; 8 of them were treated simultaneously  by the intraperitoneal 
injection of 109 bacteriophage particles; 8 other mice were treated with only 105 bac- 
teriophage particles,  and the other 8 animals were kept as untreated controls. 
The 8 control mice died within 2 to 4 days; only 2 of the animals which were treated 
with 106 particles survived, whereas 6 of the 8 having received the largest amount of 
bacteriophage (109 particles)  did so. 
It is of interest to point out that all these animals comprised part of a larger 
test already mentioned under Experiment 1.  It can be seen from Table I that 
some of the infected animals which had received 105 particles of bacteriophage 
exhibited immediate multiplication of the agent in the brain, whereas in other 
animals multiplication of the bacteriophage was delayed.  It may not be too 
far fetched to assume that the two infected animals which survived following 
treatment with  105 particles may have belonged to the group exhibiting im- 
mediate multiplication of the agent in the brain. 
In the course of many experiments, not to be described in detail, a number of 
mice were infected with smooth cultures of Shigella dysenteriae and treated with 
active Shiga bacteriophage introduced by the intraperitoneal route.  As con- 
trols, other infected mice were left untreated, or received by the intraperitoneal 166  MULTIPLICATION  OF BACTERIOP]KAGE 
TABLE  ~I 
Protect~eE~ect~B~ter~p~ge~ainstlnfect~n  ~  Mice  ~thShigelladyse~etiag 
Dose of 24 
F_~peri- No. of  Dose in cc. and nature of  hr. culture 
ment  mice  materlaliniected intraperi-  of smooth  Shiga 
toneatly  intracere- 
braUy 
A  8  --  0.003  1/8 
B  8  --  0.005  0/8 
C  6  --  0.005  0/6 
D  8  --  0.OO5  0/8 
E  6  --  0.005  0/6 
F  8  --  0.020  0/8 
44  1/~ 
B  8  0.1 cc. phage heated at  0.005 
606C. for 10 min. 
B  8  0.1 cc. 1 per cent tryp-  0.005 
tone broth 
B  8  0.1 cc. filtrate of 24 hr.  0.005 
culture  of  smooth 
Shiga  in  tryptone 
broth 
B  8  0.1 cc. filtrate of 24 hr.  0.005 
culture  of  rough 
Shiga  in  tryptone 
broth 
B  8  0.5  cc.  0.85  per  cent  0.005 
--  saline 
4O 
84 
8  0.02 cc. active phage  0.003 
8  0.10  "  "  "  0.003 
8  0.50  "  "  "  0.003 
6  0.01  "  "  "  0.005 
6  0.10  "  "  "  0.005 
7  0.10  "  "  "  0.005 
8  0.10  "  "  "  0.005 
5  0.50  "  "  "  0.005 
8  0.10  "  "  "  0.020 
64 
No, of mice  Remarks 
mrviving at  All intraperitoneal treatments given  end of 
~bservation  within I0 rain.  of intracerebral in- 
period  jection of SMgelia dysenterlae. 
1/8 
0/8 
0/8 
Virulence  controls  (no  trea-t 
ment) 
Control  mice  (treated  with 
material  containing  no  ac- 
tive  bacteriophage).  All 
doses  made  up  to  0.5  cc. 
with saline 
0/8 
0/8 
2/4o 
3/84  Mice receiving no active phage, 
3.6 per cent survivals 
7/8  Mice treated  with active bac- 
7/8  teriophage.  Preparation 
6/8  gave  between  109  and  10  t° 
5/6  plaques per cc.  No control 
4/6  of  bacterial  count  injected 
3/7  other  than  age  of  culture 
7/8  (24 hr.) 
4/5 
3/8 
46/64  Mice  receiving  active  phage, 
72 per cent survivals REN~. J. DUBOS, JUNE HOOKEY  STRAUS, AND CYNTHIA. PIERCE  167 
route, saline, broth filtrates of cultures of rough and smooth Shigella dysenteriae, 
or bacteriophage  inactivated by heat.  The results of a number of such pro- 
tection experiments are summarized in Table III.  These results reveal that of 
the control mice (untreated, or treated with inactive material)  infected with 
0.005 cc. Shigdta dysenteriae,  only 3.6 per cent survived; whereas 72 per cent of 
the infected animals treated with active bacteriophage were saved. 
In other experiments, effective protection was also obtained when bacterio- 
phage was administered intravenously or subcutaneously instead of intraperi- 
toneaUy.  Administration of the agent per os (by stomach tube or mixed with 
drinking water) did not influence the course of the infection. 
DISCUSSION 
Anti-Shiga  bacteriophage  introduced  intraperitoneally  into  normal  white 
mice can be detected in the brain within 1 hour after injection, but the number 
of bacteriophage particles per gram of brain (brain level) always remains much 
smaller than the numbers present per cubic centimeter of blood (blood level). 
In mice infected intracerebrally with Shigella dysenteriae,  on the contrary, the 
intraperitoneal  injection  of  bacteriophage  rapidly  results  in  a  brain  level 
considerably higher than the blood level.  This high brain level cannot be due 
to a simple selective fixation of the circulating bacteriophage by the susceptible 
bacteria multiplying in the brain, but implies a  considerable multiplication of 
the lyric agent in vivo. 
It has also been shown that the int~aperitoneal injection of sufficient amounts 
of active bacteriophage can protect mice against intracerebral infection with 
Shigella  dysenteriae;  no protection was  obtained when bacteriophage  inacti- 
vated by heat, or culture autolysates free of bacteriophage, were used instead of 
the active agent.  Before concluding, however, that protection was the result of 
multiplication of the agent in vivo, it must be noted that a number of animals 
died even though considerable multiplication of bacteriophage had undoubtedly 
taken place; this was the case, for instance, in the mice treated with the smaller 
amount of the agent (10  ~ particles)  in Experiment 3.  It is likely that, with 
inadequate treatment,  the bacteria multiply extensively before the bacterio- 
phage reaches a  bacteriostatic or bactericidal level, so that enough toxin and 
sufficient irreversible  pathological  changes  are  produced  to  cause  death  ir- 
respective of final bacteriophage level.  On the other hand, animals treated 
with large amounts of bacteriophage (10  9 particles, for instance), survived even 
though there was no definite evidence of multiplication  of the agent in vivo. 
It is difficult to evaluate the importance of the different factors which may 
play a  part  in the protection induced by bacteriophage.  In certain experi- 
ments not reported in this paper, it was found, for instance, that the injection 
of heat-killed bacteriophage several days prior to the infection was sufficient to 168  MULTIPLICATION  O~  BACTERIOPHAGE 
afford some protection.  This protective effect may be due to the antibacterial 
immunity resulting from the injection of the bacterial products present in the 
lysate, and also to non-specific stimulation o1 phagocytic activity caused by 
broth components.  The results described in the present report, however, es- 
tablish the fact that one can produce an experimental situation in which sur- 
vival of the infected animal depends upon the presence of a  sufficiently high 
concentration of bacteriophage in the tissues at the beginning of the bacterial 
disease.  Whether the protective effect results from an ability of the bacterio- 
phage to prevent further bacterial growth, to cause lysis of the infective cells, to 
induce variation to a non-virulent form, or simply to sensitize them for phago- 
cytosis, cannot be decided on the basis of available data. 
CONCLUSIONS 
1.  Anti-Shiga bacteriophage injected into the general circulation  can mul- 
tiply in the brain of mice infected intracerebrally with  Shigella dysenteriae. 
2.  Under proper conditions, the injection of active bacteriophage  into the 
general circulation can protect mice against an otherwise fatal intracerebral 
infection with Shigella dysenteriae. 
3.  The protection so induced appears to depend upon the early establishment 
of a high bacteriophage level in the infected animal. 
Addendum.--Shortly  after the completion of this manuscript,  there appeared  in 
the Journal  of Bacteriology a paper establishing  the protective effect of a bacterio- 
phage  preparation against infection  of the chick embryo with a  Flexner  strain of 
Shigella dysenteriae (7). 
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